| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Cai,Zheng-Xian | Chairman | 32.64% | Bionet Corporation(Bionet Corp.) |
| Zhang,Cui-Ru | Director | 5.78% | GENETICS GENERATION ADVANCEMENT CORP. (GGA CORP.) |
| Liang,Yu-Lun | Director | 1.43% | CHIEN HSIN TRADING CO., LTD. |
| Zhang,Wen-Zheng | Director | 0.88% | |
| Sheng,Bao-Xi | Director | 1.43% | Baolei Co. Ltd. |
| Lin,Pi-Rong | Independent Director | 0.00% | |
| Zhuang,Fu-Jun | Independent Director | 0.00% | |
| LING STEVEN DEE | Independent Director | 0.00% | |
| Lin,Kun-Ming | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 |
|---|---|---|
| Operating income | 81,319 | 5,369 |
| Operating cost | 79,301 | 3,571 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - |
| Operating gross profit (loss) | 2,018 | 1,798 |
| Unrealized profit (loss) on sales of goods | - | - |
| Realized profit (loss) on sales of goods | - | - |
| Operating gross profit (loss), net | 2,018 | 1,798 |
| Operating expenses | 101,381 | 41,056 |
| Other gain (loss), net | - | - |
| Operating profit (loss) | -99,363 | -39,258 |
| Non-operating income and expenses | 13,105 | 1,920 |
| Net profit (loss) before tax | -86,258 | -37,338 |
| Income tax expense (benefits) | 0 | 0 |
| Net profit (loss) of ongoing business for the current period | -86,258 | -37,338 |
| Profit (loss) of closed units | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - |
| Net profit (loss) for the current period | -86,258 | -37,338 |
| Other comprehensive profit (loss), net | -5,080 | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - |
| Total comprehensive profit and loss for the current period | -91,338 | -37,338 |
| Net profit (loss) attributable to owners of parent company | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - |
| Basic earnings per share (yuan) | -1 | -2 |
| 項目 | 2024 | 2023 |
|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - |
| Net cash inflows (outflows) from investing activities | - | - |
| Net cash inflow (outflow) from financing activities | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - |
| Beginning balance of cash and cash equivalents | - | - |
| Ending balance of cash and cash equivalents | - | - |
| 項目 | 2024 | 2023 |
|---|---|---|
| Current asset | 1,274,970 | 528,346 |
| Non-current asset | 75,052 | 11,835 |
| Total asset | 1,350,022 | 540,181 |
| Current liability | 53,702 | 12,088 |
| Non-current liability | - | - |
| Total liability | 53,702 | 12,088 |
| share capital | 700,000 | 450,287 |
| Equity - secruity token | - | - |
| capital reserve | 735,095 | 125,243 |
| retained earning | -133,695 | -47,437 |
| Other equity | -5,080 | - |
| Treasury stock | - | - |
| Total equity attributable to owners of parent company | - | - |
| Equity attributable to former owner of business combination under common control | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - |
| Non-controlling interests | - | - |
| Total Equity | 1,296,320 | 528,093 |
| Share capital awaiting retirement (unit: share) | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 |
| Net asset value per share | 18 | 11 |
